Caxton Associates LP Amgen Inc Transaction History

Caxton Associates LP

$2.65 Billion
Q3 2024

A detailed history of Caxton Associates LP transactions in Amgen Inc stock. As of the latest transaction made, Caxton Associates LP holds 5,674 shares of AMGN stock, worth $1.48 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

5,674

Previous 2,364 140.02%

Holding current value

$1.48 Million

Previous $738,000 147.7%

% of portfolio

0.07%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $1.02 Million - $1.12 Million	3,310 Added 140.02%	5,674 $1.83 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $2.84 Million - $3.46 Million	-10,822 Reduced 82.07%	2,364 $738,000
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $25,004 - $30,184	-93 Reduced 0.7%	13,186 $3.75 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $2.51 Million - $2.83 Million	9,804 Added 282.13%	13,279 $3.82 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $1.04 Million - $1.29 Million	-4,770 Reduced 57.85%	3,475 $933,000
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $1.77 Million - $2.09 Million	8,245 New	8,245 $1.83 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $314,458 - $399,556	1,373 New	1,373 $360,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $760,420 - $846,215	3,296 New	3,296 $802,000
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $452,639 - $503,372	-1,929 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $381,575 - $468,245	1,929 New	1,929 $455,000
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $471,748 - $529,874	-2,841 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $679,922 - $794,574	-4,013 Reduced 58.55%	2,841 $484,000
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $1.16 Million - $1.29 Million	6,854 New	6,854 $1.19 Million
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $468,412 - $534,800	-2,800 Closed	0 $0
Q2 2017 Aug 29, 2017	BUY	N/A	2,800	2,800 $482,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.

Account

Caxton Associates LP Amgen Inc Transaction History